Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$38.9B
sum of reported positions
Reported positions
652
Changes vs prior quarter
791
244 new · 197 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 557 measured positions in 8 quarters, the typical new or larger position finished −1.9 pts against the S&P 500 and 44% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
ISHARES TR | 4.53M | $3.4B | 8.8% |
| 10.9M | $1.08B | 2.8% | |
| 1.49M | $838M | 2.2% | |
| 4.66M | $730M | 1.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $35.4B | $38.9B |
| Positions | 605 | 652 |
| Biggest line | — | ISHARES TR 9% |
| 3.17M |
| $538M |
| 1.4% |
| 1.34M | $499M | 1.3% |
| 1.07M | $424M | 1.1% |
| 1.77M | $422M | 1.1% |
| 2.32M | $409M | 1.1% |
| 23.4M | $371M | 1.0% |
| 775K | $356M | 0.9% |
| 895K | $356M | 0.9% |
| 1.05M | $333M | 0.9% |
| 1.25M | $329M | 0.8% |
| 2.48M | $319M | 0.8% |
| 1.17M | $298M | 0.8% |
| 3.04M | $292M | 0.8% |
| 856K | $283M | 0.7% |
| 1.71M | $282M | 0.7% |
| 291K | $281M | 0.7% |
| 6.81M | $269M | 0.7% |
| 1.85M | $261M | 0.7% |
| 2.73M | $251M | 0.6% |
| 984K | $246M | 0.6% |
| 11.3M | $244M | 0.6% |
Legend Biotech (LEGN)
11K → 307K shares (+2827%)
Tamboran Resources (TBN)
271K shares
Verastem (VSTM)
2.05M → 2.29M shares (+12%)
Vistra Corp. (VST)
55K shares
Newmark Group (NMRK)
574K shares
Mirum Pharmaceuticals (MIRM)
34K → 74K shares (+117%)
Datadog (DDOG)
51K → 33K shares (−35%)
Babcock & Wilcox Enterprises (BW)
613K shares
Almonty Industries (ALM)
240K → 519K shares (+116%)
Lithia Motors (LAD)
21K → 29K shares (+40%)
Choice Hotels (CHH)
76K shares
Oruka Therapeutics (ORKA)
185K → 88K shares (−53%)
Scotts Miracle-Gro Company (SMG)
122K shares
Cardinal Infrastructure Group (CDNL)
50K → 87K shares (+73%)
Kimberly-Clark (KMB)
74K shares
Acadia Pharmaceuticals (ACAD)
310K shares
Option Care Health (OPCH)
1.78M → 369K shares (−79%)
Applied Aerospace & Defense (AADX)
338K shares
Polaris (PII)
111K shares
Veradermics (MANE)
62K shares
Brazil Potash (GRO)
3.24M → 3.4M shares (+5%)
OSISKO DEVELOPMENT CORP
2.92M shares
Grail (GRAL)
645K → 105K shares (−84%)
Whitehawk Minerals (WHK)
250K shares
Huntington Bancshares (HBAN)
392K shares
